Xenon Pharmaceuticals IncXenon Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG rating for Xenon Pharmaceuticals Inc represents its transparency towards the United Nations SDGs. If you are employed by Xenon Pharmaceuticals Inc and you would like to licence your Sustainability aseessment, please contact us. The page contains a zero-cost ESG report covering Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 4.8, social score of 4.8 and governance score of 8.0.

SDG Transparency Score for Xenon Pharmaceuticals Inc 
Low
0 - 3

6.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Xenon Pharmaceuticals Inc 
4.8

Environmental

4.8

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
563ReproCell Inc
6.3
High
563Venus Remedies Ltd
6.3
High
586Xenon Pharmaceuticals Inc
6.2
High
586Althea Group Holdings Ltd
6.2
High
586AlzeCure Pharma AB
6.2
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Xenon Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Xenon Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Xenon Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Xenon Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Xenon Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Xenon Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Xenon Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Sorry!

Failed to process!